Clinical Trial Update: Rivaroxaban for Patients With Antiphospholipid Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rivaroxaban for antiphospholipid syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Antiphospholipid Syndrome | Phase 3 | Status: COMPLETED